{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T19:20:32Z","timestamp":1768677632353,"version":"3.49.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"crossref","award":["1R01HL121294-01A1"],"award-info":[{"award-number":["1R01HL121294-01A1"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["P30AI036211"],"award-info":[{"award-number":["P30AI036211"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["P30CA125123"],"award-info":[{"award-number":["P30CA125123"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["S10RR024574"],"award-info":[{"award-number":["S10RR024574"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000097","name":"National Center for Research Resources","doi-asserted-by":"crossref","award":["S10RR024574"],"award-info":[{"award-number":["S10RR024574"]}],"id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"crossref","award":["AI036211"],"award-info":[{"award-number":["AI036211"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"crossref","award":["P30CA125123"],"award-info":[{"award-number":["P30CA125123"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jtcvsonline.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Thoracic and Cardiovascular Surgery"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.jtcvs.2016.09.041","type":"journal-article","created":{"date-parts":[[2016,9,23]],"date-time":"2016-09-23T17:34:25Z","timestamp":1474652065000},"page":"329-339.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["In situ reprogramming to transdifferentiate fibroblasts into cardiomyocytes using adenoviral vectors: Implications for clinical myocardial regeneration"],"prefix":"10.1016","volume":"153","author":[{"given":"Megumi","family":"Mathison","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivek P.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria J.","family":"Chiuchiolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepthi","family":"Sanagasetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivekkumar B.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianchang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen M.","family":"Kaminsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald G.","family":"Crystal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd K.","family":"Rosengart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtcvs.2016.09.041_bib1","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.cell.2010.07.002","article-title":"Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors","volume":"142","author":"Ieda","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.jtcvs.2016.09.041_bib2","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nature11139","article-title":"Heart repair by reprogramming non-myocytes with cardiac transcription factors","volume":"485","author":"Song","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jtcvs.2016.09.041_bib3","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1161\/CIRCRESAHA.112.269035","article-title":"MicroRNA-mediated in\u00a0vitro and in\u00a0vivo direct reprogramming of cardiac fibroblasts to cardiomyocytes","volume":"110","author":"Jayawardena","year":"2012","journal-title":"Circ Res"},{"key":"10.1016\/j.jtcvs.2016.09.041_bib4","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.yjmcc.2012.04.010","article-title":"A new approach to transcription factor screening for reprogramming of fibroblasts to cardiomyocyte-like cells","volume":"53","author":"Protze","year":"2012","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.jtcvs.2016.09.041_bib5","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.stemcr.2013.07.005","article-title":"Direct reprogramming of human fibroblasts toward a cardiomyocyte-like state","volume":"1","author":"Fu","year":"2013","journal-title":"Stem Cell Rep"},{"key":"10.1016\/j.jtcvs.2016.09.041_bib6","doi-asserted-by":"crossref","first-page":"5588","DOI":"10.1073\/pnas.1301019110","article-title":"Reprogramming of human fibroblasts toward a cardiac fate","volume":"110","author":"Nam","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jtcvs.2016.09.041_bib7","doi-asserted-by":"crossref","first-page":"12667","DOI":"10.1073\/pnas.1304053110","article-title":"Induction of human cardiomyocyte-like cells from fibroblasts by defined factors","volume":"110","author":"Wada","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jtcvs.2016.09.041_bib8","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.jtcvs.2016.09.041_bib9","doi-asserted-by":"crossref","first-page":"e63577","DOI":"10.1371\/journal.pone.0063577","article-title":"Transcription factors MYOCD, SRF, Mesp1 and SMARCD3 enhance the cardio-inducing effect on GATA4, TBX5, and MEF2C during direct cellular reprogramming","volume":"8","author":"Christoforou","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.jtcvs.2016.09.041_bib10","doi-asserted-by":"crossref","first-page":"e89678","DOI":"10.1371\/journal.pone.0089678","article-title":"Inhibition of TGF\u03b2 signaling increases direct conversion of fibroblasts to induced cardiomyocytes","volume":"9","author":"Ifkovits","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jtcvs.2016.09.041_bib11","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.15252\/embj.201387605","article-title":"MiR-133 promotes cardiac reprogramming by directly repressing Snai1 and silencing fibroblast signature","volume":"33","author":"Muraoka","year":"2014","journal-title":"EMBO J"},{"key":"10.1016\/j.jtcvs.2016.09.041_bib12","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1161\/CIRCRESAHA.116.305547","article-title":"Stoichometry of Gata4, Mef2c, and Tbx5 influences the efficiency and quality of induced cardiac myocyte reprogramming","volume":"116","author":"Wang","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.jtcvs.2016.09.041_bib13","doi-asserted-by":"crossref","first-page":"8243","DOI":"10.1038\/ncomms9243","article-title":"High-efficiency reprogramming of fibroblasts into cardiomyocytes requires suppression of pro-fibrotic signaling","volume":"6","author":"Zhao","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.jtcvs.2016.09.041_bib14","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.stemcr.2015.10.019","article-title":"Fibroblast growth factors and vascular endothelial growth factor promote cardiac\u00a0reprogramming under defined conditions","volume":"5","author":"Yamakawa","year":"2015","journal-title":"Stem Cell Reports"},{"key":"10.1016\/j.jtcvs.2016.09.041_bib15","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.stem.2016.02.003","article-title":"Bmi1 is a key epigenetic barrier to direct cardiac reprogramming","volume":"18","author":"Zhou","year":"2016","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jtcvs.2016.09.041_bib16","doi-asserted-by":"crossref","first-page":"e005652","DOI":"10.1161\/JAHA.112.005652","article-title":"In\u00a0vivo\u00a0cardiac cellular reprogramming efficacy is enhanced by angiogenic preconditioning of the infarcted myocardium with vascular endothelial growth factor","volume":"1","author":"Mathison","year":"2012","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jtcvs.2016.09.041_bib17","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1016\/j.jtcvs.2014.03.033","article-title":"\u201cTriplet\u201d polycistronic vectors encoding Gata4, Mef2c, and Tbx5 enhances postinfarct ventricular functional improvement compared with singlet vectors","volume":"148","author":"Mathison","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtcvs.2016.09.041_bib18","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/nature11044","article-title":"In\u00a0vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes","volume":"485","author":"Qian","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jtcvs.2016.09.041_bib19","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1161\/CIRCRESAHA.112.271148","article-title":"Induction of cardiomyocyte-like cells in infarct hearts by gene transfer of Gata4, Mef2c, and Tbx5","volume":"111","author":"Inagawa","year":"2012","journal-title":"Circ Res"},{"key":"10.1016\/j.jtcvs.2016.09.041_bib20","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1161\/CIRCRESAHA.116.304510","article-title":"MicroRNA induced cardiac reprogramming in\u00a0vivo Evidence for mature cardiac myocytes and improved cardiac function","volume":"116","author":"Jayawardena","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.jtcvs.2016.09.041_bib21","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1056\/NEJM200301163480314","article-title":"A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency","volume":"348","author":"Hacein-Bey-Abina","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtcvs.2016.09.041_bib22","doi-asserted-by":"crossref","first-page":"218","DOI":"10.2174\/156652311795684740","article-title":"Current advances in retroviral gene therapy","volume":"11","author":"Yi","year":"2011","journal-title":"Curr Gene Ther"},{"key":"10.1016\/j.jtcvs.2016.09.041_bib23","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.stem.2008.02.001","article-title":"Defining molecular cornerstones during fibroblast to iPS cell reprogramming in mouse","volume":"2","author":"Stadtfeld","year":"2008","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jtcvs.2016.09.041_bib24","first-page":"137","article-title":"Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in\u00a0vivo","volume":"3","author":"Yang","year":"1996","journal-title":"Gene Ther"},{"key":"10.1016\/j.jtcvs.2016.09.041_bib25","first-page":"376","article-title":"Antivector and antitransgene host responses in gene therapy","volume":"2","author":"Hackett","year":"2000","journal-title":"Curr Opin Mol Ther"},{"key":"10.1016\/j.jtcvs.2016.09.041_bib26","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.ymthe.2005.03.031","article-title":"Alteration of splicing signals in a genomic\/cDNA hybrid VEGF gene to modify the ration of expressed VEGF isoforms enhances safety of angiogenic gene therapy","volume":"12","author":"Amano","year":"2005","journal-title":"Mol Ther"},{"key":"10.1016\/j.jtcvs.2016.09.041_bib27","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0092-8674(92)90213-V","article-title":"In\u00a0vivo transfer of the human cystic fibrosis transmembrane\u00a0conductance regulator gene to the airway epithelium","volume":"68","author":"Rosenfeld","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.jtcvs.2016.09.041_bib28","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1172\/JCI117243","article-title":"Characterization of angiotensin II receptors in cultured adult rat cardiac fibroblasts: coupling to signaling systems and gene expression","volume":"93","author":"Crabos","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jtcvs.2016.09.041_bib29","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1172\/JCI41651","article-title":"Nicotinic acid inhibits progression of atherosclerosis in mice through its receptor GPR109A expressed by immune cells","volume":"121","author":"Lukasova","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jtcvs.2016.09.041_bib30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/hum.2013.2527","article-title":"Adenovirus: the first effective in\u00a0vivo gene delivery vector","volume":"25","author":"Crystal","year":"2014","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.jtcvs.2016.09.041_bib31","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1089\/hum.1995.6.10-1265","article-title":"Transient expression of genes transferred in\u00a0vivo into heart using first-generation adenoviral vectors: role of the immune response","volume":"6","author":"Gilgenkrantz","year":"1995","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.jtcvs.2016.09.041_bib32","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2174\/1566523213666131125095046","article-title":"Adenovirus vectors for gene therapy, vaccination and cancer gene therapy","volume":"13","author":"Wold","year":"2013","journal-title":"Curr Gene Ther"},{"key":"10.1016\/j.jtcvs.2016.09.041_bib33","doi-asserted-by":"crossref","first-page":"e51711","DOI":"10.1371\/journal.pone.0051711","article-title":"Residual expression of reprogramming factors affects the transcriptional program and epigenetic signatures of induced pluripotent stem cells","volume":"7","author":"Sommer","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jtcvs.2016.09.041_bib34","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2174\/156652311796150372","article-title":"Adenoviral vector immunity: its implications and circumvention strategies","volume":"11","author":"Ahi","year":"2011","journal-title":"Curr Gene Ther"},{"key":"10.1016\/j.jtcvs.2016.09.041_bib35","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1089\/10430340152712647","article-title":"Analysis of risk factors for local delivery of low- and intermediate-dose adenovirus gene transfer vectors to individuals with a spectrum of comorbid conditions","volume":"13","author":"Crystal","year":"2002","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.jtcvs.2016.09.041_bib36","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.jtcvs.2003.09.049","article-title":"Angiogenic pre-treatment improves the efficacy of cellular cardiomyoplasty performed with fetal cardiomyocyte implantation","volume":"127","author":"Retuerto","year":"2004","journal-title":"J Thorac Cardiovasc Surg"}],"container-title":["The Journal of Thoracic and Cardiovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002252231631159X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002252231631159X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:44:36Z","timestamp":1548981876000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002252231631159X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S002252231631159X"],"URL":"https:\/\/doi.org\/10.1016\/j.jtcvs.2016.09.041","relation":{},"ISSN":["0022-5223"],"issn-type":[{"value":"0022-5223","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In situ reprogramming to transdifferentiate fibroblasts into cardiomyocytes using adenoviral vectors: Implications for clinical myocardial regeneration","name":"articletitle","label":"Article Title"},{"value":"The Journal of Thoracic and Cardiovascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtcvs.2016.09.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 by The American Association for Thoracic Surgery","name":"copyright","label":"Copyright"}]}}